Actual Medicinal Product (AMP) Lansoprazole 30mg gastro-resistant capsules (Medical Valley Invest AB)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Moisture sensitive medicine. Store in airtight (sealed) MCA. Stability study supports 8 weeks in MCA.
- Provenance
-
This recommendation is based on the products lansoprazole 30mg capsules (Accord-UK Ltd) and lansoprazole 30mg capsules (Activase Pharmaceuticals Limited).
- Generic
- Lansoprazole
- Formulation
- Lansoprazole 30mg gastro-resistant capsules
-
Lansoprazole
-
Lansoprazole 30mg gastro-resistant capsules
-
Lansoprazole 30mg gastro-resistant capsules (Medical Valley Invest AB)
-
-
Lansoprazole 15mg orodispersible tablets